Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Orthovita to launch bone void filler in Europe:

This article was originally published in Clinica

Executive Summary

Orthovita has CE-marked for sale in Europe its synthetic cancellous bone void filler for filling bony gaps in the skeletal system. The Vitoss Scaffold, a resorbable calcium phosphate, is delivered as a pre-formed scaffold matrix that resembles the porosity of normal cancellous bone. The product is replaced as bone remodels. Malvern, Pennsylvania-based Orthovita said the scaffold marked the company's first product entry into the orthopaedic spine and trauma bone substitute markets. It will launch the product in Europe in September and has submitted it to the FDA for US market clearance.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076666

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel